ASM Communications

ASM Communications

Parasites that cause malaria can lurk in plain sight, including in deer in North America. 

Researchers have found that mice living in New York City’s residential buildings harbor multiple bacteria species that can cause human fever and gastrointestinal disease, including Salmonella, Clostridium difficile, Escherichia coli and Leptospira species.


A team of Swiss investigators has found a new mechanism that is critical to the ability of certain avian influenza A viruses to infect humans.

Antimicrobial susceptibility testing is a common topic on Bugs & Drugs, but where to get started? The ASM-CLSI Webinar series is a great place to learn AST foundational concepts important for all clinical microbiologists.

The new Journal of Microbiology and Biology Education issue focuses on science communication. Guest Editor Jesus Romo highlights articles about scicomm training for early-career scientists and using those skills for community and institutional engagement!

To better understand the molecular drivers behind resistance, researchers at the Centers for Disease Control and Prevention (CDC) recently conducted a whole-genome analysis of an unusual bacterial strain cultured from a patient in the United States.

Fungi found in the gastrointestinal tracts of healthy adults are largely transient and stem from the mouth or foods recently consumed, according to new research published this week in mSphere, an open access journal from the American Society for Microbiology.

The CDC is warning about the possibility of gonorrhea becoming “untreatable”. In part one of a three-part series, we will discuss the long history of antimicrobial treatment for gonococcal infections, and find out why antimicrobial resistance in Neisseria gonorrhoeae has been classified as an urgent threat to public health.

The American Society for Microbiology congratulates Congress for the passage today of a Fiscal Year 2018 spending package that is integral to scientific advancements and public health.

ASM looks forward to working with Dr. Redfield as the CDC continues to tackle critical public health issues such as antimicrobial resistance, vaccine development for influenza, and emergency preparedness for emerging bio threats both in the U.S. and abroad.

Page 1 of 17